165 Scalp, palmoplantar, and nail involvement in moderate bio-naive psoriasis patients treated with apremilast: 6-week interim results of a real-world, multicenter,  prospective study in Greece

The efficacy of apremilast on scalp, palmoplantar, and nail psoriasis in moderate psoriatic bio-naive patients after 6 weeks of treatment was assessed. Interim data for the first 100 patients [mean age at baseline (i.e. at apremilast onset): 49.9 years; mean age at diagnosis: 40.3 years; 71.0% male; 41.0% obese; mean Psoriasis Area Severity Index: 12.8; 66.0% previously treated with conventional systemic treatments] are presented, using last-observation-carried-forward imputation. At baseline, 77.6% (76/98), 29.6% (29/98), and 62.5% (60/96) of the patients, had Scalp Physician ’s Global Assessment (ScPGA), Palmoplantar Psoriasis PGA (PPPGA), and Nail Psoriasis Severity Index (NAPSI) scores>0, respectively.
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: Tags: Clinical Research and Epidemiology Source Type: research